ACE2 and COVID-19: Importantly, recent findings further support positive genetic association of circulating ACE2 with severe COVID‐19, CVD, asthma, diabetes, and hypertension, as well as causal effect of circulating ACE2 on COVID‐19 infection, hospitalization, and severity.14